We observed increasing expression levels of cleaved caspase-3 suggesting an activation of extrinsic apoptotic mechanism and a reduction of survivin indicating that pioglitazone seems to exert an anti-cancer effect by modulating both survival and apoptotic markers. The gene discussed is CASP3; the disease is cancer.